 Albuterol
"Albuterol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
| Descriptor ID |
D000420
|
| MeSH Number(s) |
D02.033.100.291.057 D02.092.063.291.057 D02.092.471.683.061
|
| Concept/Terms |
Albuterol- Albuterol
- 2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
- Salbutamol
Levalbuterol Hydrochloride- Levalbuterol Hydrochloride
- Hydrochloride, Levalbuterol
- Levosalbutamol Hydrochloride
- Hydrochloride, Levosalbutamol
|
Below are MeSH descriptors whose meaning is more general than "Albuterol".
Below are MeSH descriptors whose meaning is more specific than "Albuterol".
This graph shows the total number of publications written about "Albuterol" by people in UAMS Profiles by year, and whether "Albuterol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 0 | 3 | 3 | | 2021 | 2 | 0 | 2 | | 2020 | 1 | 0 | 1 | | 2019 | 2 | 1 | 3 | | 2018 | 0 | 1 | 1 | | 2017 | 2 | 1 | 3 | | 2016 | 0 | 1 | 1 | | 2015 | 4 | 0 | 4 | | 2014 | 1 | 0 | 1 | | 2013 | 2 | 1 | 3 | | 2012 | 1 | 0 | 1 | | 2011 | 1 | 0 | 1 | | 2010 | 4 | 0 | 4 | | 2009 | 0 | 1 | 1 | | 2007 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2003 | 2 | 2 | 4 | | 1998 | 1 | 0 | 1 | | 1997 | 2 | 0 | 2 | | 1996 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Albuterol" by people in Profiles over the past ten years.
-
Willis LD, Danner NP, Lloyd TL, Carper NL, Berlinski A. Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation. Respir Care. 2022 11; 67(11):1396-1404.
-
Berlinski A. Changing Positions When New Data Are Available Is Essential to Science: A Tale of a Breath-Enhanced Nebulizer. Respir Care. 2022 08; 67(8):1064-1065.
-
Cox C, Patel K, Cantu R, Akmyradov C, Irby K. Hypokalemia Measurement and Management in Patients With Status Asthmaticus on Continuous Albuterol. Hosp Pediatr. 2022 02 01; 12(2):198-204.
-
Qaqish R, Berlinski A. Effects of Shake-Actuation Delay on Delivered Dose and Aerosol Characteristics of an Albuterol Suspension From a Pressurized Metered-Dose Inhaler. Respir Care. 2021 Aug; 66(8):1315-1322.
-
Berlinski A. In Vitro Comparison of Different Nebulizers Delivering 7% Hypertonic Saline. Respir Care. 2021 Oct; 66(10):1582-1587.
-
Pertzborn MC, Prabhakaran S, Abu-Hasan M, Baker D, Wu S, Wu Y, Hendeles L. Continuous Albuterol With Benzalkonium in Children Hospitalized With Severe Asthma. Pediatrics. 2020 04; 145(4).
-
Berlinski A, Velasco J. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With a Single-Limb Circuit. Respir Care. 2019 Nov; 64(11):1366-1370.
-
Berlinski A. Be Aware of Intrapulmonary Percussive Ventilation. Respir Care. 2019 05; 64(5):612-613.
-
Kennedy JL, Kurten RC, McCullough S, Panettieri RA, Koziol-White C, Jones SM, Caid K, Gill PS, Roberts D, Jaeschke H, McGill MR, James L. Acetaminophen is both bronchodilatory and bronchoprotective in human precision cut lung slice airways. Xenobiotica. 2019 Sep; 49(9):1106-1115.
-
Awad SM, Berlinski A. Crossover Evaluation of Compressors and Nebulizers Typically Used by Cystic Fibrosis Patients. Respir Care. 2018 Mar; 63(3):294-300.
-
Velasco J, Berlinski A. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit. Respir Care. 2018 Feb; 63(2):141-146.
-
Berlinski A, Pennington D. Effect of Interval Between Actuations of Albuterol Hydrofluoroalkane Pressurized Metered-Dose Inhalers on Their Aerosol Characteristics. Respir Care. 2017 Sep; 62(9):1123-1130.
-
Helm ME. Value-Based Insurance Design Pharmacy Benefits for Children and Youth With Special Health Care Needs: Principles and Opportunities. Pediatrics. 2017 May; 139(Suppl 2):S117-S126.
-
Berlinski A, Cooper B. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber. Respir Care. 2016 Jul; 61(7):913-9.
-
Berlinski A. Transnasal Aerosol Delivery to Pediatric Patients: Jet Versus Vibrating Mesh--Reply. Respir Care. 2015 Oct; 60(10):e168-9.
-
Cooper B, Berlinski A. Albuterol Delivery via Facial and Tracheostomy Route in a Model of a Spontaneously Breathing Child. Respir Care. 2015 Dec; 60(12):1749-58.
-
Berlinski A, Willis JR. Effect of Tidal Volume and Nebulizer Type and Position on Albuterol Delivery in a Pediatric Model of Mechanical Ventilation. Respir Care. 2015 Oct; 60(10):1424-30.
-
El Taoum KK, Xi J, Kim J, Berlinski A. In Vitro Evaluation of Aerosols Delivered via the Nasal Route. Respir Care. 2015 Jul; 60(7):1015-25.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|